secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001171843-23-005235
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology Q2 net loss $3.9M on revenue $490K; cash burn $7M in H1 2023
--------------------------------------------------------------------------------

- Net loss of $3.9M ($0.98 per share) vs $2.89 loss per share in Q2 2022.
- Revenue rose 32% to $490,110 from $371,591; gross margin improved to 67% from 64%.
- Cash and equivalents $14.8M, down from $22.1M at Dec 31, 2022; equity $14.7M.
- G&A expenses increased by $353K to $2.7M; sales & marketing up $158K to $429K.
- Business updates: collaborations with CRH and Cvergenx, new board members, HQ moved to Pittsburgh.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323005235/0001171843-23-005235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323005235/f8k_081023.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-005235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer